Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial

Name: Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial
License: Public Domain

Zhejiang Cancer Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

advanced breast cancer, her2-negative breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 417553
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.